CCMA Medications Cheat Sheet

Lisinopril is an ACE inhibitor, which carries a black box warning for fetal toxicity and is strictly contraindicated for patients who are currently in her first trimester or any stage of pregnancy. Methyldopa is a central alpha agonist that is widely indicated and considered safe for managing gestational hypertension. Labetalol is a beta blocker frequently used as a first-line treatment for high blood pressure in pregnant patients. Nifedipine is a calcium channel blocker that is also safely indicated for hypertension during pregnancy.

Transdermal patches deliver medication at a controlled rate through the skin into the systemic circulation. Applying a heating pad causes local vasodilation, which significantly increases blood flow to the area. Option A is correct because this increased perfusion accelerates absorption, causing the drug to enter the bloodstream much faster than intended, potentially leading to a fatal overdose. Option B is incorrect because heat increases, rather than decreases, capillary distribution. Option C is incorrect because the half-life is an inherent property of how the body clears the drug, not how fast it is absorbed. Option D is incorrect because absorption does not prevent the liver from eventually metabolizing the drug.

Electronic health records utilize clinical alerts to prevent adverse medication events. When a drug-drug interaction alert appears during medication reconciliation, the medical assistant must document the finding and escalate it to the provider. The provider is responsible for evaluating the clinical significance of the interaction and adjusting the treatment plan if necessary. Option A is incorrect because deleting a medication from the record falsifies the patient's actual regimen and hides vital clinical data from the provider. Option B is incorrect because advising a patient to stop a medication constitutes giving medical advice, which strictly violates the medical assistant's scope of practice. Option C is incorrect because bypassing the warning based solely on a lack of current side effects ignores potential long-term risks or asymptomatic organ damage that the provider needs to evaluate.